4 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18324563 | PHOSPHORYLATED TRISTETRAPROLIN AS A BIOMARKER AND THERAPEUTIC TARGET FOR ANTIAGING DRUGS | BAUSCH, SARAE L | 1699 | Non-Final OA | May 26, 2023 |
| 18122839 | COMBINATIONS OF AN ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY, A PLATINUM-BASED ANTINEOPLASTIC DRUG, AND A TAXANE | XIAO, YAN | 1642 | Non-Final OA | Mar 17, 2023 |
| 18102263 | EYE-TRACKING DEVICE AND METHOD FOR TESTING VISUAL PROCESSING CAPABILITIES | OGLES, MATTHEW ERIC | 3791 | Final Rejection | Jan 27, 2023 |
| 16973573 | A METHOD OF PRECISION CANCER THERAPY | SULLIVAN, STEPHANIE LAUREN | 1635 | Final Rejection | Dec 09, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial